Literature DB >> 15479823

Influence of gag on human immunodeficiency virus type 1 species-specific tropism.

Yasuhiro Ikeda1, Laura M J Ylinen, Maria Kahar-Bador, Greg J Towers.   

Abstract

The narrow host range of human immunodeficiency virus type 1 (HIV-1) is due in part to dominant acting restriction factors in humans (Ref1) and monkeys (Lv1). Here we show that gag encodes determinants of species-specific lentiviral infection, related in part to such restriction factors. Interaction between capsid and host cyclophilin A (CypA) protects HIV-1 from restriction in human cells but is essential for maximal restriction in simian cells. We show that sequence variation between HIV-1 isolates leads to variation in sensitivity to restriction factors in human and simian cells. We present further evidence for the importance of target cell CypA over CypA packaged in virions, specifically in the context of gp160 pseudotyped HIV-1 vectors. We also show that sensitivity to restriction is controlled by an H87Q mutation in the capsid, implicated in the immune control of HIV-1, possibly linking immune and innate control of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479823      PMCID: PMC523279          DOI: 10.1128/JVI.78.21.11816-11822.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Molecular recognition in the HIV-1 capsid/cyclophilin A complex.

Authors:  S Yoo; D G Myszka; C Yeh; M McMurray; C P Hill; W I Sundquist
Journal:  J Mol Biol       Date:  1997-06-27       Impact factor: 5.469

3.  The HIV type 1 replication block in nonhuman primates is not explained by differences in cyclophilin A primary structure.

Authors:  L Yin; S Boussard; J Allan; J Luban
Journal:  AIDS Res Hum Retroviruses       Date:  1998-01-01       Impact factor: 2.205

4.  Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene.

Authors:  L Bénit; N De Parseval; J F Casella; I Callebaut; A Cordonnier; T Heidmann
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A.

Authors:  D Braaten; C Aberham; E K Franke; L Yin; W Phares; J Luban
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line.

Authors:  Y Soda; N Shimizu; A Jinno; H Y Liu; K Kanbe; T Kitamura; H Hoshino
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

7.  Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes.

Authors:  F Gao; E Bailes; D L Robertson; Y Chen; C M Rodenburg; S F Michael; L B Cummins; L O Arthur; M Peeters; G M Shaw; P M Sharp; B H Hahn
Journal:  Nature       Date:  1999-02-04       Impact factor: 49.962

8.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.

Authors:  Greg J Towers; Theodora Hatziioannou; Simone Cowan; Stephen P Goff; Jeremy Luban; Paul D Bieniasz
Journal:  Nat Med       Date:  2003-08-03       Impact factor: 53.440

10.  Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels.

Authors:  L Yin; D Braaten; J Luban
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more
  49 in total

1.  Retroviral restriction factor TRIM5alpha is a trimer.

Authors:  Claudia C Mische; Hassan Javanbakht; Byeongwoon Song; Felipe Diaz-Griffero; Matthew Stremlau; Bettina Strack; Zhihai Si; Joseph Sodroski
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 2.  Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.

Authors:  Jeremy Luban
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 3.  Identification of HIV inhibitors guided by free energy perturbation calculations.

Authors:  Orlando Acevedo; Zandrea Ambrose; Patrick T Flaherty; Hadega Aamer; Prashi Jain; Somisetti V Sambasivarao
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.

Authors:  Lionel Berthoux; Sarah Sebastian; Elena Sokolskaja; Jeremy Luban
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

Review 5.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

6.  Recognition of the HIV capsid by the TRIM5α restriction factor is mediated by a subset of pre-existing conformations of the TRIM5α SPRY domain.

Authors:  Dmytro B Kovalskyy; Dmitri N Ivanov
Journal:  Biochemistry       Date:  2014-02-24       Impact factor: 3.162

7.  HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.

Authors:  Cécile Tremblay; Isabelle Hardy; Richard Lalonde; Benoit Trottier; Irina Tsarevsky; Louis-Philippe Vézina; Michel Roger; Mark Wainberg; Jean-Guy Baril
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

8.  Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.

Authors:  Zuzana Keckesova; Laura M J Ylinen; Greg J Towers
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

9.  TRIM5alpha and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors.

Authors:  Marie-Edith Nepveu-Traversy; Julie Bérubé; Lionel Berthoux
Journal:  Retrovirology       Date:  2009-11-03       Impact factor: 4.602

10.  A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen.

Authors:  Quang Toan Pham; Maxime Veillette; Alberto Brandariz-Nuñez; Paulina Pawlica; Caroline Thibert-Lefebvre; Nadia Chandonnet; Felipe Diaz-Griffero; Lionel Berthoux
Journal:  Virus Res       Date:  2013-01-25       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.